Search

Search Results

Results 8431 - 8440 of 8663 for Skin Cancer

Tuberous Sclerosis Prognosis

Health - 23 Aug 2018

The prognosis of tuberous sclerosis depends greatly on the number, size and location of the characteristic tumors associated with the condition. These factors affect the extent to which the tumors...
Vitiligo Treatment

Health - 23 Aug 2018

Vitiligo is a difficult condition to treat, but newer treatments are being researched all the time. The most common therapies may be classified as:
How Do We Sense Pain?

Health - 6 Mar 2016

Pain is a sensation that is triggered in the nervous system. It can be sharp or dull and last for short or long periods. Pain may be localized to a specific area of the body such as the abdomen, chest...
Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125

Drug - 10 Sep 2026

Consumer Medicine Information (CMI) about Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125 intended for persons living in Australia.
Amgevita

Drug - 9 Sep 2026

Consumer Medicine Information (CMI) about Amgevita intended for persons living in Australia.
Zedace

Drug - 3 Sep 2026

Consumer Medicine Information (CMI) about Zedace intended for persons living in Australia.
Nebivolol Viatris

Drug - 3 Sep 2026

Consumer Medicine Information (CMI) about Nebivolol Viatris intended for persons living in Australia.
Shingrix

Drug - 2 Sep 2026

Consumer Medicine Information (CMI) about Shingrix intended for persons living in Australia.
Hysone

Drug - 2 Sep 2026

Consumer Medicine Information (CMI) about Hysone intended for persons living in Australia.
Hydrocortisone Viatris 4 and 20 (formerly Hydrocortisone Mylan)

Drug - 2 Sep 2026

Consumer Medicine Information (CMI) about Hydrocortisone Viatris 4 and 20 (formerly Hydrocortisone Mylan) intended for persons living in Australia.

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.